00:00-00:07
[OPEN ON LAURA AND JULIA DANCING IN A CROWDED VENUE]
LAURA: Can you believe we’re doing this?
JULIA: I can’t.
CAPTION: Laura and Julia are real patients taking Mounjaro (tirzepatide). They were compensated for their time.
00:07–00:26
[INTRO SEQUENCE WITH MOUNJARO LOGO APPEARS]
NARRATOR: Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus. It is not known if Mounjaro is safe and effective for use in children.
CAPTION:
Once weekly mounjaro (tirzepatide) injection
Laura and Julia’s story will continue in 56 seconds
Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults and children 10 years of age and older with type 2 diabetes mellitus.
- It is not known if Mounjaro is safe and effective for use in children under 10 years of age.
00:26-00:53
NARRATOR: Warning. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Mounjaro and medicines that work like Mounjaro caused thyroid tumors, including thyroid cancer. It is not known if Mounjaro will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
CAPTION:
Once weekly mounjaro (tirzepatide) injection
Laura and Julia’s story will continue in 16 seconds
Select Safety Information.
Warning:
Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Mounjaro and medicines that work like Mounjaro caused thyroid tumors, including thyroid cancer. It is not known if Mounjaro will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
00:53-01:10
NARRATOR: Do not take Mounjaro if you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
See Indication and Safety Summary with Warnings at the end of this video.
CAPTION:
Once weekly mounjaro (tirzepatide) injection
Laura and Julia’s story will continue in 12 seconds
Select Safety Information.
Warning:
Do not take Mounjaro if you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). See Indication and Safety Summary with Warnings at the end of this video.
01:10-01:15
[Car passing through field with hills; Laura riding in the car.]
LAURA: In my family, I have a very long history of type two diabetes…
CAPTION: On The Move: Learning to Two-Step
once weekly Mounjaro (tirzepatide) injection logo
Laura is a real patient taking Mounjaro for type 2 diabetes.
01:15-01:17
[Car passing under bridge]
LAURA: ...unfortunately with a lot of complications.
CAPTION: Laura is a real patient taking Mounjaro for type 2 diabetes.
01:17-01:20
[Drone shot of the city]
JULIA: My type two diabetes symptoms were initially…
01:20-01:24
[Julia walking down a city street]
JULIA: ...overlooked by my primary care physician who told me to just diet and exercise.
CAPTION: Julia is a real patient taking Mounjaro for type 2 diabetes.
01:24-01:30
[Car passing in the city, Julia looking up at buildings]
JULIA: After at least a year of struggling to see improvement, I was frustrated, worried, and determined to find an answer.
CAPTION: Julia is a real patient taking Mounjaro for type 2 diabetes.
01:30-01:34
[Julia on a phone call]
JULIA: Hey Laura, I can't wait to learn the two-step with you. I’m on the move!
01:34-01:35
[Phone view of Julia]
JULIA: I’m so excited.
01:35-01:40
[Julia and Laura greeting each other at the dance studio]
LAURA: Hey, how are you?
CAPTION: Laura and Julia's First Dance Practice
01:40-01:48
[Julia and Laura greeting each other at the dance studio, then walking towards a bench]
LAURA: Over the years I watched my mom try several different diabetes treatments and lifestyle changes to treat her type two diabetes.
01:48-01:54
[Julia and Laura sitting down talking]
LAURA: So I just came to the realization either type two diabetes is going to control me, or I'm going to control it.
01:54-01:55
[Julia and Laura meeting the dance instructor]
JULIA: Let’s do it.
01:55-01:58
[Julia, Laura and instructor practicing a dance routine]
DANCE INSTRUCTOR: Six, seven, eight.
01:58-02:04
[Julia, Laura and instructor practicing a dance routine]
LAURA: I worked with my primary care physician to start on a couple different medications. And together we decided…
02:04-02:06
[Julia and Laura sitting down talking]
LAURA: …that Mounjaro could be a good option for me.
02:06-02:08
[Julia, Laura and instructor practicing a dance routine]
DANCE INSTRUCTOR: One, two, three.
02:08-02:13
[Julia, Laura and instructor practicing a dance routine]
JULIA: When I started taking Mounjaro two years ago my A1C was high. Now, it’s under seven.
CAPTION:
The majority of people taking Mounjaro reached an A1C under 7%.*
*In studies with or without other diabetes medications, 75% to 90% of patients reached an A1C of less than 7%, with an average starting A1C of 7.9% to 8.6% across the 5-mg, 10-mg, and 15-mg doses. Study results were measured at 40 and 52 weeks.
02:13-02:16
[Laura, Julia and instructor practicing a dance routine]
JULIA: My doctor and I were really happy with my progress on Mounjaro…
CAPTION: The majority of people taking Mounjaro reached an A1C under 7%.*
*In studies with or without other diabetes medications, 75% to 90% of patients reached an A1C of less than 7%, with an average starting A1C of 7.9% to 8.6% across the 5-mg, 10-mg, and 15-mg doses. Study results were measured at 40 and 52 weeks.
02:16-02:19
[Laura, Julia, and instructor practicing a dance routine]
JULIA: …and I’ve been following my diet and exercise plan.
CAPTION: The majority of people taking Mounjaro reached an A1C under 7%.*
*In studies with or without other diabetes medications, 75% to 90% of patients reached an A1C of less than 7%, with an average starting A1C of 7.9% to 8.6% across the 5-mg, 10-mg, and 15-mg doses. Study results were measured at 40 and 52 weeks.
02:19-02:22
[Laura and Julia practicing with the dance instructor]
LAURA: Same here. I saw my blood sugar decrease and I started to lose some weight.
CAPTION:
People taking Mounjaro lost up to 25 lb.
Mounjaro is not a weight loss drug.
Individual results may vary. In studies with or without other diabetes medications, weight loss in adults ranged from 12 lb (5 mg) to 25 lb (15 mg).
02:22-02:25
[Julia and Laura sitting showing dance videos on their phone]
JULIA: Check out these moves. You can tell we've been practicing.
CAPTION: People taking Mounjaro lost up to 25 lb.
Mounjaro is not a weight loss drug.
Individual results may vary. In studies with or without other diabetes medications, weight loss in adults ranged from 12 lb (5 mg) to 25 lb (15 mg).
02:25-2:27
[Julia and Laura sitting showing dance videos on their phone]
LAURA: Oh my gosh, that’s so awesome.
JULIA: Isn’t that awesome?
02:27-02:29
[Videos of Julia and Laura dancing display on a phone]
LAURA: For me...
02:29-02:30
[A video of Laura dancing displayed on a phone]
LAURA: ...noticing the progress I’m making
02:30-02:33
[Laura and Julia sitting looking at a phone]
LAURA: I feel excited and have a positive outlook.
02:33-02:35
[Julia, Laura, and instructor practicing dance routine]
LAURA: I can focus on the things I enjoy.
02:35-02:41
[Julia, Laura, and instructor practicing dance routine]
JULIA: It really is empowering. It really does make you want to get up and keep trying even on the days when it feels really hard.
02:41-02:42
[Julia, Laura, and instructor practicing dance routine]
BACKGROUND: You did so good. I'm so proud of you.
02:42-02:45
[Laura and Julia walking into the venue]
CAPTION: The Big Night! Showing off their Dance Moves.
02:45-02:47
[Julia and Laura line dancing at the venue]
LAURA: Now that my blood sugar is better...
02:47-02:52
[Julia and Laura line dancing at the venue]
LAURA: ...I feel so empowered having a different frame of mind that I really am in the control seat.
CAPTION:
Up to 90% of people taking Mounjaro reached an A1C under 7%.*
*In studies with or without other diabetes medications, 75% (5mg) to 90% (10mg) of people taking Mounjaro reached an A1C <7%. Average starting A1C was 7.9% to 8.6% across the 5-, 10-, 15-mg doses. In a study of basal insulin with or without Mounjaro, 90% of people taking Mounjaro 10-mg with basal insulin reached A1C <7% vs basal insulin alone.
02:52-03:05
[Julia and Laura line dancing at the venue]
JULIA: Before I would just kind of watch from the sidelines. Lowering my A1C, changing habits with diet and exercise really motivated me, and they’ve helped me feel like I can be an active participant.
CAPTION: Up to 90% of people taking Mounjaro reached an A1C under 7%.*
*In studies with or without other diabetes medications, 75% (5mg) to 90% (10mg) of people taking Mounjaro reached an A1C <7%. Average starting A1C was 7.9% to 8.6% across the 5-, 10-, 15-mg doses. In a study of basal insulin with or without Mounjaro, 90% of people taking Mounjaro 10-mg with basal insulin reached A1C <7% vs basal insulin alone.
03:05-03:06
[Julia and Laura line dancing at the venue]
JULIA: I’m on the move!
03:06-03:10
[Julia and Laura line dancing at the venue]
LAURA: I am on the move!
03:10-03:14
[Animated Mounjaro logo appears on screen with CTA end card]
CAPTION: Talk to your doctor about once-weekly Mounjaro
Once weekly Mounjaro (tirzepatide) injection
A Lilly Medicine
For more details and pricing information, visit Mounjaro.Lilly.com or call 1-800-545-5979 (1-800-LillyRX).
Mounjaro® and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
03:14-04:32
[CBS animates full screen and begins scrolling]
CAPTION: once weekly Mounjaro® (tirzepatide) injection
INDICATION AND SAFETY SUMMARY WITH WARNINGS
Mounjaro® (mown-JAHR-OH) is an injectable medicine for adults and children 10 years of age and older with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose).
• It is not known if Mounjaro is safe and effective for use in children under 10 years of age.
Warnings – Mounjaro may cause tumors in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If you have any of these symptoms, tell your healthcare provider.
• Do not use Mounjaro if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).
• Do not use Mounjaro if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Do not use Mounjaro if you are allergic to it or any of the ingredients in Mounjaro.
Mounjaro may cause serious side effects, including:
Inflammation of the pancreas (pancreatitis). Stop using Mounjaro and call your healthcare provider right away if you have severe pain in your stomach area without nausea or vomiting. Sometimes you may feel the pain from your abdomen to your back.
04:32-06:45
CAPTION:
Low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Mounjaro with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, or mood changes, hunger, weakness and feeling jittery.
Serious allergic reactions. Stop using Mounjaro and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, and very rapid heartbeat.
Dehydration leading to kidney problems. Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away.
Severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Mounjaro. Tell your healthcare provider if you have stomach problems that are severe or will not go away.
Changes in vision. Tell your healthcare provider if you have changes in vision during treatment with Mounjaro.
Gallbladder problems. Gallbladder problems have happened in some people who use Mounjaro. Tell your healthcare provider right away if you get symptoms of gallbladder problems, which may include pain in your upper stomach (abdomen), fever, yellowing of skin or eyes (jaundice), and clay-colored stools.
Food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). Mounjaro may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your healthcare providers that you are taking Mounjaro before you are scheduled to have surgery or other procedures.
06:45-09:42
CAPTION:
Common side effects
The most common side effects of Mounjaro include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach (abdominal) pain. These are not all the possible side effects of Mounjaro. Talk to your healthcare provider about any side effect that bothers you or doesn’t go away.
Tell your healthcare provider if you have any side effects. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.
Before using Mounjaro
• Your healthcare provider should show you how to use Mounjaro before you use it for the first time.
• Talk to your healthcare provider about low blood sugar and how to manage it.
• If you take birth control pills by mouth, talk to your healthcare provider before you use Mounjaro. Birth control pills may not work as well while using Mounjaro. Your healthcare provider may recommend another type of birth control for 4 weeks after you start Mounjaro and for 4 weeks after each increase in your dose of Mounjaro.
Review these questions with your healthcare provider:
☐ Do you have other medical conditions, including problems with your pancreas, or severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems digesting food?
☐ Do you take other diabetes medicines, such as insulin or sulfonylureas?
☐ Do you have a history of diabetic retinopathy?
☐ Are you scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation)?
☐ Are you pregnant, plan to become pregnant, breastfeeding, or plan to breastfeed? It is not known if Mounjaro will harm your unborn baby. Mounjaro may pass into your breast milk.
☐ Do you take any other prescription medicines or over-the-counter drugs, vitamins, or herbal supplements?
How to take
• Read the Instructions for Use that come with Mounjaro.
• Use Mounjaro exactly as your healthcare provider says.
• A caregiver may give you Mounjaro injections, or you may self-inject if a healthcare provider determines that it is appropriate.
• Inject Mounjaro under the skin (subcutaneously) of your stomach (abdomen), thigh, or another person should inject in the back of the upper arm. Do not inject Mounjaro into a muscle (intramuscularly) or vein (intravenously).
• Use Mounjaro 1 time each week, at any time of the day.
• Do not mix insulin and Mounjaro together in the same injection.
• You may give an injection of Mounjaro and insulin in the same body area (such as your stomach area), but not right next to each other.
• Change (rotate) your injection site with each weekly injection. Do not use the same site for each injection.
• If you take too much Mounjaro, call your healthcare provider or Poison Help line at 1-800-222-1222 or go to the nearest hospital emergency room right away.
09:42-10:47
CAPTION:
Learn more
Mounjaro is a prescription medicine available as a pre-filled single-dose pen in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL injection. For more information, call 1-800-LillyRX (800-545-5979) or go to www.mounjaro.lilly.com.
This summary provides basic information about Mounjaro but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your healthcare provider. Be sure to talk to your healthcare provider about Mounjaro and how to take it. Your healthcare provider is the best person to help you decide if Mounjaro is right for you.
TR CON CBS 19DEC2025
The Mounjaro logo, Mounjaro®, and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Some voice over generated by AI.
10:47-10:57
CAPTION:
once weekly Mounjaro (tirzepatide) injection logo
A Lilly Medicine
Lilly logo
CAPTION: Mounjaro® and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
CMAT-11503 02/2026
©Lilly USA, LLC 2026. All rights reserved.